Figures & data
Table 1. Baseline characteristics of patients with UGIB in the uremia group.
Table 2. Laboratory data of patients with UGIB in the uremia group based on survival and mortality.
Table 3. Acid suppressive drugs and ulcerogenic drugs used by patients with uremia in the UGIB group based on survival and mortality.
Table 4. Cox proportional hazards model analysis for predicting UGIB outcomes in patients with uremia.